The registry study aims to determine serial biomarkers to diagnosis and prognosis of aortic aneurysm/aortic dissection.
The study aims to investigate the role of candidate biomarkers in the diagnosis and prognosis of AA and AD. In the diagnosis part, we begin with a discovery phase where individually matched case-control study. Patients within each disease outcomes (i.e. AD, AMI, PE, AA without AD and healthy controls) are age and sex matched and retrospectively included.In the prognosis part of the study, patients with confirmed AA and AD are enrolled. The primary outcome is the all-cause mortality based on the death certificates. The secondary outcome is the in-hospital mortality according to the patients'medical records.
Study Type
OBSERVATIONAL
Enrollment
1,500
Beijing Anzhen Hospital
Beijing, Beijing Municipality, China
RECRUITINGDignosis of each participant
1. Patients with Aneurysm/Dissection had image information from ultrasound cardiograms and computed tomography to confirm the final diagnosis. 2. AMI if they had chest pain lasting \>20 min, diagnostic serial ECG changes comprising new pathological Q waves or ST-segment and T-wave changes, and a plasma creatine kinase-MB elevation greater than twice the normal level or cardiac troponin I (cTnI) level greater than 0.1 ng/mL. 3. Diagnosis of PE was confirmed by positive spiral computed tomography or pulmonary angiography, a high probability on ventilation perfusion scintigraphy, or a proximal deep vein thrombosis documented on compression ultrasonography or angiography.
Time frame: These data is collected from the cases' medical record in an average of 6 month after the sample recruiting
Prognosis of each participant
Prognosis information including all-cause mortality and in-hospital mortality.
Time frame: These data is collected from the cases' medical record or during follow-up visit at 2-4 years after discharge.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.